A new study has identified a drug that potentially could make a common type of immunotherapy for cancer even more effective, Cedars-Sinai Medical Center announced Wednesday. The study in laboratory mice found that the drug dasatinib, which is FDA-approved to treat certain types of leukemia, greatly enhances responses to a form of immunotherapy that is […]